Cargando...
Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo
Bispecific antibodies are a rapidly growing class of therapeutic molecules, originally developed for the treatment of cancer but recently explored for the treatment of autoimmune and infectious diseases. Bordetella pertussis is a reemerging pathogen, and several of the key symptoms of infection are...
Gardado en:
| Publicado en: | Clin Vaccine Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5098018/ https://ncbi.nlm.nih.gov/pubmed/27581436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00371-16 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|